Figure 4From: Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s DiseaseExpression data (mRNA levels) for betaglycan, decorin, syndecan, biglycan, MMP1 and FGF2 obtained from control (C), sporadic (SAD) and familial (FAD) Alzheimer’s disease fibroblasts treated or not with FGF2 (+). The mRNA levels were quantified by real-time quantitative PCR. Values were the mean ± SD of three independent experiments each performed in triplicate for n=10 subjects for group. Data were analyzed by ANOVA. The results were expressed as fold change in β-actin normalized mRNA values. Differences vs. mRNA levels in each respective control; *F-test significant at 99%; **F-test significant at 95%; NS = not significant. Differences vs. mRNA levels in each untreated group; §F-test significant at 99%; ns = not significantBack to article page